---
category: news
title: "Charles River (CRL) to Create New Gene Therapy for Hemophilia A"
excerpt: "Charles River Laboratories International, Inc. CRL recently inked an agreement with ASC Therapeutics, a privately-held biopharmaceutical company, to manufacture a second-generation gene therapy for hemophilia A,"
publishedDateTime: 2022-06-14T15:03:00Z
originalUrl: "https://www.nasdaq.com/articles/charles-river-crl-to-create-new-gene-therapy-for-hemophilia-a"
webUrl: "https://www.nasdaq.com/articles/charles-river-crl-to-create-new-gene-therapy-for-hemophilia-a"
ampWebUrl: "https://www.nasdaq.com/articles/charles-river-crl-to-create-new-gene-therapy-for-hemophilia-a?amp"
cdnAmpWebUrl: "https://www-nasdaq-com.cdn.ampproject.org/c/s/www.nasdaq.com/articles/charles-river-crl-to-create-new-gene-therapy-for-hemophilia-a?amp"
type: article

provider:
  name: Nasdaq
  domain: nasdaq.com

topics:
  - AI in Healthcare
  - AI

secured: "VmLhrY9E31Hqfu/nI2mZZ2Nidi+zBEcaP8GcTHMjEYcAaPhcVf2QiLI+KYOuOQkGvND4s12KcTGAiWh9/pNNUc0qAOU1LS7VkElDHiD+NB2yxBVgJZ8qhTkvCjK+QVkvR0GOe8g+908ZXMtTu9UbgUPfno6+QB/U8EtVtWOGGm97L6Zgks3S5soZv8fe/k9OOqX/y9g2KKM7d8SbqY8XtHE0pUkTWkiQkaFR/ofqZYFot7TY2nllJVcTbiTVzrPaVtvPFNLZX29DRGHC0HM87IH7cipKS2ISyBkKB9q4Oo9YtwVMPpVXHpQ95Oi7Sg7xpSrM0hG5oZPMjIlH9TtiI4ifhJYnbeU4jD/8DY1GMRY=;ifWLYbwpoC5TAWz+9j3ZgA=="
---

